Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.79 |
| ▸ | CA2 | P00918 | 2/20 | 0.79 |
| ▸ | CA7 | P43166 | 2/20 | 0.79 |
| ▸ | CA9 | Q16790 | 2/20 | 0.79 |
| ▸ | CA12 | O43570 | 1/20 | 0.79 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.79 |
| ▸ | LTA4H | P09960 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL166536 | 1.00 | CA1 (0.79) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11580995 | 1.00 | CA1 (0.79) | CA1CA2CA7CA9CA12 | |
| Phosphine SCHEMBL22689591 | 0.97 | LTA4H (0.74) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13038584 | 0.91 | LTA4H (0.67) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7610770 | 0.91 | LTA4H (0.67) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.89 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.89 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| SCHEMBL491503 | 0.88 | LTA4H (1.00) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12277315 | 0.88 | ACHE (0.83) | CA1CA2CA7CA9CA12 | |
| SCHEMBL257625 | 0.88 | ACHE (0.83) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108495-A1 | VIRAL INHIBITORS, THE SYNTHESIS THEROF, AND INTERMEDIATES THERETO | TAKEDA PHARMACEUTICALS CO (JP) | 2026-04-23 | — | — | US | claimed |
| EP-3746309-B1 | HEAT-SENSITIVE RECORDING MATERIAL | MITSUBISHI HITEC PAPER EUROPE GMBH (DE) | 2026-01-28 | — | — | EP | claimed |
| US-12454144-B2 | Heat-sensitive recording material comprising phenol-free organic colour developers | MITSUBISHI HITEC PAPER EUROPE GMBH (DE) | 2025-10-28 | — | — | US | claimed |
| WO-2025021929-A1 | HYDROPHILIC TRANS-CYCLOOCTENE (HYTCO) COMPOUNDS, CONSTRUCTS AND CONJUGATES CONTAINING THE SAME | VERAXA BIOTECH GMBH (DE) | 2025-01-30 | — | — | WO | claimed |
| US-20250002735-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONALOBJECTS THEREFROM | STRATASYS INC (US) | 2025-01-02 | — | — | US | claimed |
| US-20240209029-A1 | ADIPONECTIN GLYCOPEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2024-06-27 | — | — | US | claimed |
| US-20240010601-A1 | METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS (VLCFA) | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2024-01-11 | — | — | US | claimed |
| CN-117255780-A | Adiponectin glycopeptides and compositions and methods of use thereof | 香港大学 | 2023-12-19 | — | — | CN | claimed |
| US-11752793-B2 | Heat-sensitive recording material | MITSUBISHI HITEC PAPER EUROPE GMBH (DE) | 2023-09-12 | — | — | US | claimed |
| EP-4203940-A1 | METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS (VLCFA) | The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) | 2023-07-05 | — | — | EP | claimed |
| US-8039676-B2 | Process for producing phosphine oxide vitamin D precursors | CYTOCHROMA INC. (CA) | 2011-10-18 | — | — | US | claimed |
| JP-2011508053-A | — | — | 2011-03-10 | — | — | JP | claimed |
| EP-2242776-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF Corporation (US) | 2010-10-27 | — | — | EP | claimed |
| EP-2167516-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | Cytochroma Inc. (CA) | 2010-03-31 | — | — | EP | claimed |
| CN-101495657-A | Nucleic Acid Amplification Using Reversibly Modified Oligonucleotides | WANLI BI (US) | 2009-07-29 | — | — | CN | claimed |
| WO-2009088596-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-16 | — | — | WO | claimed |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | EIRGEN PHARMA LTD. (IE) | 2008-12-04 | — | — | US | claimed |
| WO-2008146130-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYTOCHROMA INC. (CA) | 2008-12-04 | — | — | WO | claimed |
| US-20030215871-A1 | Chemically inert molecular tags | PHARMACOPEIA, INC. (US) | 2003-11-20 | — | — | US | claimed |
| US-20030186810-A1 | Heat-sensitive recording material | MITSUBISHI PAPER MILLS LTD. | 2003-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030215871-A1 | Chemically inert molecular tags | ALK, ADH1A, ADH1C | CA1 330/4885CA2 2534/4885CA7 286/4885 |
| US-20240209029-A1 | ADIPONECTIN GLYCOPEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF | ADIPOR1, ADIPOR2, PTMS | CA1 3604/4885CA2 4599/4885CA7 3760/4885 |
| US-20240010601-A1 | METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS (VLCFA) | ELOVL1, ELOVL3, HACD3 | CA1 3207/4885CA2 4166/4885CA7 2845/4885 |
| US-20080300427-A1 | PROCESS FOR PRODUCING PHOSPHINE OXIDE VITAMIN D PRECURSORS | CYP24A1, VDR, FRG1 | CA1 1257/4885CA2 1083/4885CA7 1407/4885 |
| US-20260108495-A1 | VIRAL INHIBITORS, THE SYNTHESIS THEROF, AND INTERMEDIATES THERETO | HYOU1, CYP2F1, HAVCR2 | CA1 801/4885CA2 756/4885CA7 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.